Forbes reports that pharmaceutical giant GlaxoSmithKline’s stock prices haven’t dropped at all in the wake of a historic $3 billion settlement with the U.S. Justice Department over illegally marketing drugs.
“Paying the Department of Justice settlements are apparently just a cost of the drug business,” Forbes states.
According to Forbes, GlaxoSmithKline sold medication to treat depression in kids under 18, despite a lack of pediatric approval. It also promoted depression drug Wellbutrin ...
continue reading...
In a recent article in the scientific journal Scientifica, two mental health professionals call for a redefinition of the term “antidepressant.”
A report in the Florida Times-Union concerns a man suing two doctors whom he blames for his wife’s death from a blood clot, because they failed to take her off the birth control pill Yasmin before her plastic surgery.
According to an article in the Wilkes Barre Times Leader, a new study aims to answer the question of whether the toxic fluids used in natural gas drilling can pose a threat to drinking water.
The Coalition to Prevent Deep-Vein Thrombosis provides a list of frequently asked questions to educate people about this potentially deadly condition.
